Azithromycin [Design Issues]

posted by kumarnaidu – Mumbai, India, 2016-01-11 13:51 (3459 d 11:52 ago) – Posting: # 15811
Views: 5,466

Dear All,
Recently we did one pilot study on Azithromycin Suspension. In this study we found that the reference drug is showing two peaks. And the study fails for the Cmax. Can anybody suggest what could be the possible reason for getting this kind of concentration curve for reference?

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,676 registered users;
46 visitors (0 registered, 46 guests [including 5 identified bots]).
Forum time: 02:43 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5